The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy

Asa J. Nixon(Dana-Farber Brigham Cancer Center), Jay R. Harris(Harvard University), Abram Recht(Beth Israel Deaconess Medical Center), Donna Neuberg(Otsuka (Japan)), James L. Connolly(Beth Israel Deaconess Medical Center), Anthony Abner(Dana-Farber Brigham Cancer Center), Stuart J. Schnitt(Brigham and Women's Hospital)
International Journal of Radiation Oncology*Biology*Physics
August 1, 1994
10.1016/0360-3016(94)90514-2
Cited by 97

Related Papers

An immunogenic personal neoantigen vaccine for patients with melanoma
|Nature|2017|3k
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
|Cell|2013|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k